Lorcaserin Phentermine among non-surgical and surgical obese patients: Anthropometric, glycemic, lipid, safety and cost outcomes.

Background: To evaluate effectiveness, safety, and costs of Lorcaserin phentermine among obese non-surgical and surgical patients (post bariatric surgery).

Methods: This retrospective study retrieved charts of all patients (January 2013-June 2016) who received Lorcaserin or phentermine for 3 months. The study assessed anthropometric, glycemic, and lipid changes, as well as side effects and cost of medications among overweight and obese non-surgical (n = 83) and surgical patients (n = 46).